Cipher Pharmaceuticals Inc Stock Other OTC
Stocks
CA17253X1050
Pharmaceuticals
OTC Markets Traded| Market Cap | 339M 238M 214M 199M 181M 22.62B 341M 2.39B 934M 11.74B 892M 873M 37.75B | P/E 2026 * |
11.9x | P/E 2027 * | 11x |
|---|---|---|---|---|---|
| Enterprise Value | 339M 238M 214M 199M 181M 22.62B 341M 2.39B 934M 11.74B 892M 873M 37.75B | EV / Sales 2026 * |
4.79x | EV / Sales 2027 * | 4.17x |
| Free-Float |
57.46% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cipher Pharmaceuticals Inc
| 1 day | -22.72% |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Mull
CEO | Chief Executive Officer | - | 29/07/2019 |
Ryan Mailling
DFI | Director of Finance/CFO | - | 10/08/2024 |
Bryan Jacobs
DFI | Director of Finance/CFO | - | 15/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Mull
CHM | Chairman | - | 12/06/2019 |
Douglas Deeth
BRD | Director/Board Member | 78 | 21/06/2023 |
Hubert Walinski
BRD | Director/Board Member | - | 21/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -22.72% | -5.31% | - | - | 242M | |
| +3.62% | +1.68% | +48.80% | +98.41% | 1,040B | |
| +2.13% | -1.76% | +33.04% | +61.88% | 599B | |
| +3.32% | +4.47% | +23.72% | +91.59% | 485B | |
| +3.80% | +3.21% | +73.99% | +41.69% | 350B | |
| +3.09% | +3.03% | +29.59% | +45.42% | 345B | |
| +2.82% | +2.20% | +17.90% | +40.15% | 272B | |
| +3.40% | +0.99% | -3.44% | +12.08% | 244B | |
| +3.21% | +3.15% | +45.01% | +49.99% | 223B | |
| +3.80% | +4.56% | +29.59% | +97.73% | 183B | |
| Average | +0.44% | +1.90% | +33.13% | +59.88% | 415.87B | |
| Weighted average by Cap. | +2.66% | +1.53% | +36.79% | +68.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 70.85M 49.62M 44.62M 41.64M 37.74M 4.72B 71.29M 500M 195M 2.45B 186M 182M 7.88B | 81.35M 56.98M 51.23M 47.81M 43.33M 5.42B 81.86M 574M 224M 2.81B 214M 209M 9.05B |
| Net income | 27.7M 19.4M 17.44M 16.28M 14.75M 1.85B 27.87M 195M 76.28M 958M 72.84M 71.26M 3.08B | 31.76M 22.25M 20M 18.67M 16.92M 2.12B 31.96M 224M 87.47M 1.1B 83.52M 81.71M 3.53B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
